Back to the Mental Health Monitor
Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey
SALT LAKE CITY, October 11, 2021 – Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they won’t seek treatment for mental health conditions and others say they won’t get help until these symptoms take a toll in their lives.
Video assets
Managing Anxiety
Photo gallery
After working with her doctor to manage her anxiety, Anna was able to excel in her career and go back to school, accomplishments that felt impossible when anxiety ruled her life.
Anna takes medication to manage her anxiety. After working with her doctor and taking the GeneSight test, she says finding effective treatment has made her feel like herself again.
Dr. Robin Miller consults with a patient at Triune Integrative Medicine. A new survey by the GeneSight Mental Health Monitor found that 86% of those who are diagnosed with anxiety rated their anxiety symptoms as moderate to severe over the past six months. More than half of those respondents said they lived with symptoms for years or even decades before seeking treatment.
Anna worked with her doctor to find a medication to treat her anxiety with the help of the GeneSight test, which analyzes how a patient’s genes may affect their outcomes with medications commonly prescribed for anxiety, depression, ADHD, and other psychiatric conditions.
The GeneSight Mental Health Monitor is a nationwide survey conducted by ACUPOLL Precision Research, Inc. during Aug.-Sept. 2021 among a statistically representative sample of adults age 21+, including a representative sample diagnosed with anxiety. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.